New FDA Approved Inhalers for Asthma and COPD Patients in the Market

Breo Ellipta by GSK

  • Its a dry powder inhaler only approved for COPD patients and not for Asthma patients
  • Main draw back is if you open and then close the inhaler cover without inhaling the medicine, one dose is lost & the inhaler comes only with 30 doses
  • You have to be careful while using Breo Ellipta, do not open cover until you are ready to inhale

Arnuity Ellipta by GSK

  • Its a dry powder inhaler only approved for Asthma patients
  • Good thing about Ellipta inhaler is that It is not possible to accidentally take a double dose or  an extra dose in 1 inhalation through this device

IrFloso Forspiro by Vectura

  • This inhaler is FDA approved in Latin America. This can be used for Asthma and COPD patients
  • An innovative device that has visual control features which helps reassure the patient about dosing, simple lever arm to load the dose & clear and accurate dose counter